Skip to main content
OpenTrials

Clinical trial condition

B-cell Lymphoma

Explore clinical trials studying B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

84 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

B-cell Lymphoma trial results

Active, not recruiting

Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers

NCT07162181

Conditions
B-cell Lymphoma, Chronic Disease, Disease Attributes, +17 more
Locations
  • Beijing Cancer hospital Beijing, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Harbin Medical University Cancer Hospital Harbin, China
  • Shanghai East Hospital Shanghai, China
View Trial Details
Active, not recruiting

Venetoclax Plus Inotuzumab for B-ALL

NCT05016947

Conditions
ALL, B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, +17 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies

NCT05270057

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • University of Texas Southwestern Dallas, Texas, United States
  • University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
  • Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

NCT05024045

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 23 locations
View Trial Details
Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 13 locations
View Trial Details
Completed

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

NCT03740529

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +35 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • Scripps Coastal Medical Center San Diego, California, United States
  • University of California San Francisco, Medical Center at Paranassus San Francisco, California, United States
  • Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States
View all 56 locations
View Trial Details
Completed

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

NCT03424122

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Arizona Cancer Center - Out Pt. Tucson, Arizona, United States
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • Comprehensive Cancer Center of Nevada Las Vegas, Nevada, United States
  • Texas Oncology Austin, Texas, United States
View all 21 locations
View Trial Details

Related conditions